Evidence map›Paper›PMID 26123828›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2016

Long-term changes in renal function and perfusion in heart failure patients with reduced ejection fraction.

Nicolas F Schroten, Kevin Damman, Mattia A E Valente, Tom D Smilde, Dirk J van Veldhuisen, Gerjan Navis, Carlo A Gaillard, Adriaan A Voors, Hans L Hillege

Open access · hybridAbstract read
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Long-term effects of device-guided slow breathing in stable heart failure patients with reduced ejection fraction.Clinical research in cardiology : official journal of the German Cardiac Society · 2019
    Trial
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Review
  13. Article
  14. Article
  15. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nicolas F SchrotenDepartment of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. nicolasschroten@gmail.com.
Kevin DammanDepartment of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
Mattia A E ValenteDepartment of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
Tom D SmildeDepartment of Cardiology, Scheper Ziekenhuis, Emmen, The Netherlands.
Dirk J van VeldhuisenDepartment of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
Gerjan NavisDepartment of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Carlo A GaillardDepartment of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands.
Adriaan A VoorsDepartment of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
Hans L HillegeDepartment of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. J.L.Hillege@umcg.nl.
University Medical Center Groningen · NLTreant Zorggroep · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLittle is known about the natural course of renal function and renal hemodynamics in heart failure patients with reduced ejection fraction (HFREF). METHODS AND

resultsWe prospectively studied effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) in 73 HFREF patients with (125)I-iothalamate/(131)I-hippuran clearances with a mean follow-up of 34.6 ± 4.4 months. Fifteen percent were female, with age 58 ± 12 years and left ventricular ejection fraction (LVEF) 29 ± 10%. Baseline GFR was 81 ± 23 mL/min/1.73 m(2) and declined 0.6 ± 4.7 mL/min/1.73 m(2) per year. Baseline ERPF was 292 ± 83 mL/min/1.73 m(2) and declined 4.3 ± 19 mL/min/1.73 m(2) per year. Of the baseline variables, older age and high urinary kidney injury molecule-1 were the only variables associated with GFR decline (p < 0.05). Following stepwise backward analysis, only age (p < 0.001) remained significant. In addition, we found an association between change in GFR and changes in ERPF, N-terminal pro-brain natriuretic peptide and renovascular resistance. In the multivariable analysis, only the change in ERPF remained significantly associated with a change in GFR (p < 0.001).

conclusionIn this cohort of stable chronic HFREF patients, the average decline in GFR over time was small. The decline of GFR was associated with a higher age and a lower baseline GFR, and was strongly related to changes in renal perfusion.

Indexed as

AgedAge FactorsFemaleFollow-Up StudiesGlomerular Filtration RateHeart FailureHemodynamicsHumansIodohippuric AcidIothalamic AcidKidney DiseasesKidney Function TestsMaleMiddle AgedMultivariate AnalysisProspective StudiesIodohippuric AcidIothalamic AcidBiomarkersCardiorenalHeart failureKidneyRenal blood flow

Identifiers

PMID26123828
PMCPMC4712227
OpenAlexW780043939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.